| 1.8 0.08 (4.65%) | 07-16 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.26 | 1-year : | 2.54 |
| Resists | First : | 1.93 | Second : | 2.18 |
| Pivot price | 1.88  |
|||
| Supports | First : | 1.54 | Second : | 1.28 |
| MAs | MA(5) : | 1.75 |
MA(20) : | 1.84 |
| MA(100) : | 1.49 |
MA(250) : | 1.41 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 22.7 |
D(3) : | 26.5 |
| RSI | RSI(14): 50.3 |
|||
| 52-week | High : | 5.76 | Low : | 0.61 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ QSI ] has closed above bottom band by 32.5%. Bollinger Bands are 4.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.82 - 1.83 | 1.83 - 1.84 |
| Low: | 1.67 - 1.68 | 1.68 - 1.69 |
| Close: | 1.78 - 1.8 | 1.8 - 1.82 |
Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
Tue, 15 Jul 2025
Quantum-Si to Report Second Quarter 2025 Financial Results on August 5, 2025 - BioSpace
Mon, 14 Jul 2025
Quantum-Si to Report Second Quarter 2025 Financial Results on August 5, 2025 - The Globe and Mail
Mon, 07 Jul 2025
Quantum-Si Raises $50M through Registered Direct Offering - AInvest
Thu, 03 Jul 2025
Quantum-Si’s Surging Stocks: An Analytical Dive - StocksToTrade
Tue, 24 Jun 2025
Quantum-Si Platinum® Pro Instrument Placed at the Broad Institute to Support Regional Research Initiatives - Yahoo Finance
Thu, 22 May 2025
Quantum-Si: Sell On Weak Prospects And Risk Of Further Dilution - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 182 (M) |
| Held by Insiders | 1.4675e+008 (%) |
| Held by Institutions | 13.9 (%) |
| Shares Short | 23,500 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.0587e+008 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -2 % |
| Return on Assets (ttm) | 982.4 % |
| Return on Equity (ttm) | -25.3 % |
| Qtrly Rev. Growth | 3.44e+006 % |
| Gross Profit (p.s.) | 28.93 |
| Sales Per Share | -13.83 |
| EBITDA (p.s.) | 625430 |
| Qtrly Earnings Growth | -0.7 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -91 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.14 |
| Price to Cash Flow | 3.87 |
| Dividend | 0 |
| Forward Dividend | 2.383e+007 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|